Literature DB >> 16569876

Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine.

P Agnamey1, P Brasseur, P Eldin de Pecoulas, Michel Vaillant, P Olliaro.   

Abstract

We have monitored the in vitro sensitivities of Plasmodium falciparum isolates predeployment and during the deployment of artesunate plus amodiaquine treatment in Mlomp, Casamance (southwestern Senegal) during 2000 to 2004. Parasites remained susceptible to both drugs. Chloroquine resistance levels were high but stable. Quinine continues to be effective.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16569876      PMCID： PMC1426962          DOI： 10.1128/AAC.50.4.1531-1534.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Combating malaria morbidity and mortality by reducing transmission.

Authors:  J F Trape; C Rogier
Journal:  Parasitol Today       Date:  1996-06

2.  A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

Authors:  P Druilhe; A Moreno; C Blanc; P H Brasseur; P Jacquier
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

3.  Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal.

Authors:  P Agnamey; P Brasseur; M Cisse; O Gaye; J Dumoulin; J Rigal; W R J Taylor; P Olliaro
Journal:  Trop Med Int Health       Date:  2005-09       Impact factor: 2.622

4.  Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450.

Authors:  J M Grace; A J Aguilar; K M Trotman; J O Peggins; T G Brewer
Journal:  Drug Metab Dispos       Date:  1998-04       Impact factor: 3.922

5.  Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.

Authors:  M Adjuik; P Agnamey; A Babiker; S Borrmann; P Brasseur; M Cisse; F Cobelens; S Diallo; J F Faucher; P Garner; S Gikunda; P G Kremsner; S Krishna; B Lell; M Loolpapit; P B Matsiegui; M A Missinou; J Mwanza; F Ntoumi; P Olliaro; P Osimbo; P Rezbach; E Some; W R J Taylor
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

6.  Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance.

Authors:  A Moreno; P Brasseur; N Cuzin-Ouattara; C Blanc; P Druilhe
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.184

7.  High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985.

Authors:  P Brasseur; P Druilhe; J Kouamouo; O Brandicourt; M Danis; S R Moyou
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

8.  In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents.

Authors:  B Pradines; A Tall; D Parzy; A Spiegel; T Fusai; R Hienne; J F Trape; J C Doury
Journal:  J Antimicrob Chemother       Date:  1998-09       Impact factor: 5.790

9.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans.

Authors:  F C Churchill; L C Patchen; C C Campbell; I K Schwartz; P Nguyen-Dinh; C M Dickinson
Journal:  Life Sci       Date:  1985-01-07       Impact factor: 5.037
View more
  14 in total

1.  Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.

Authors:  Frederick N Baliraine; Samuel L Nsobya; Jane Achan; James K Tibenderana; Ambrose O Talisuna; Bryan Greenhouse; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.

Authors:  John Okombo; Steven M Kiara; Josea Rono; Leah Mwai; Lewa Pole; Eric Ohuma; Steffen Borrmann; Lynette Isabella Ochola; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

3.  Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.

Authors:  Fatima Nawaz; Samuel L Nsobya; Moses Kiggundu; Moses Joloba; Philip J Rosenthal
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

4.  Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms.

Authors:  Christian Roussilhon; Philippe Brasseur; Patrice Agnamey; Jean-Louis Pérignon; Pierre Druilhe
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

5.  Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.

Authors:  Nathalie Wurtz; Bécaye Fall; Aurélie Pascual; Silmane Diawara; Kowry Sow; Eric Baret; Bakary Diatta; Khadidiatou B Fall; Pape S Mbaye; Fatou Fall; Yaya Diémé; Christophe Rogier; Raymond Bercion; Sébastien Briolant; Boubacar Wade; Bruno Pradines
Journal:  Malar J       Date:  2012-06-13       Impact factor: 2.979

6.  Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.

Authors:  Bécaye Fall; Silmane Diawara; Kowry Sow; Eric Baret; Bakary Diatta; Khadidiatou B Fall; Pape S Mbaye; Fatou Fall; Yaya Diémé; Christophe Rogier; Boubacar Wade; Raymond Bercion; Bruno Pradines
Journal:  Malar J       Date:  2011-10-20       Impact factor: 2.979

7.  Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.

Authors:  Jane Achan; James K Tibenderana; Daniel Kyabayinze; Fred Wabwire Mangen; Moses R Kamya; Grant Dorsey; Umberto D'Alessandro; Philip J Rosenthal; Ambrose O Talisuna
Journal:  BMJ       Date:  2009-07-21

8.  Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.

Authors:  Bécaye Fall; Aurélie Pascual; Fatoumata D Sarr; Nathalie Wurtz; Vincent Richard; Eric Baret; Yaya Diémé; Sébastien Briolant; Raymond Bercion; Boubacar Wade; Adama Tall; Bruno Pradines
Journal:  Malar J       Date:  2013-03-20       Impact factor: 2.979

9.  Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs.

Authors:  Michel Vaillant; Piero Olliaro
Journal:  Malar J       Date:  2007-11-26       Impact factor: 2.979

10.  Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.

Authors:  Piero L Olliaro; Henriette Delenne; Moustafa Cisse; Malick Badiane; Alberto Olliaro; Michel Vaillant; Philippe Brasseur
Journal:  Malar J       Date:  2008-11-07       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.